HIRSCHMAN ORIN 13D and 13G filings for scPharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-31 4:05 pm Purchase | 2024-12-31 | 13G | scPharmaceuticals Inc. SCPH | HIRSCHMAN ORIN | 4,200,577 8.400% | 1,093,782 (+35.21%) | Filing |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | scPharmaceuticals Inc. SCPH | HIRSCHMAN ORIN | 3,106,795 8.700% | 556,561 (+21.82%) | Filing |
| 2023-02-15 06:39 am Unchanged | 2022-12-31 | 13G | scPharmaceuticals Inc. SCPH | HIRSCHMAN ORIN | 2,550,234 7.500% | 0 (Unchanged) | Filing |
| 2022-11-25 06:04 am Purchase | 2022-11-22 | 13G | scPharmaceuticals Inc. SCPH | HIRSCHMAN ORIN | 2,550,234 7.500% | 2,550,234 (New Position) | Filing |